These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15093755)

  • 1. Acute and sustained effects of dihydropyridine-type calcium channel antagonists on oxidative stress in systemic sclerosis.
    Allanore Y; Borderie D; Lemaréchal H; Ekindjian OG; Kahan A
    Am J Med; 2004 May; 116(9):595-600. PubMed ID: 15093755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte transmembrane electron transfer in haemodialysis patients.
    Matteucci E; Cupisti A; Caprioli R; Battipaglia E; Favilla S; Rindi P; Barsotti G; Giampietro O
    Nutr Metab Cardiovasc Dis; 2007 May; 17(4):288-93. PubMed ID: 17434051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactive oxygen species and antioxidant status in essential arterial hypertension during therapy with dihydropyridine calcium channel antagonists.
    Digiesi V; Fiorillo C; Cosmi L; Rossetti M; Lenuzza M; Guidi D; Pace S; Rizzuti G; Nassi P
    Clin Ter; 2000; 151(1):15-8. PubMed ID: 10822876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nifedipine protects against overproduction of superoxide anion by monocytes from patients with systemic sclerosis.
    Allanore Y; Borderie D; Périanin A; Lemaréchal H; Ekindjian OG; Kahan A
    Arthritis Res Ther; 2005; 7(1):R93-100. PubMed ID: 15642147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum protein oxidation in patients with rheumatoid arthritis and effects of infliximab therapy.
    Lemarechal H; Allanore Y; Chenevier-Gobeaux C; Kahan A; Ekindjian OG; Borderie D
    Clin Chim Acta; 2006 Oct; 372(1-2):147-53. PubMed ID: 16716286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress parameters in different systemic rheumatic diseases.
    Firuzi O; Fuksa L; Spadaro C; Bousová I; Riccieri V; Spadaro A; Petrucci R; Marrosu G; Saso L
    J Pharm Pharmacol; 2006 Jul; 58(7):951-7. PubMed ID: 16805955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nifedipine decreases sVCAM-1 concentrations and oxidative stress in systemic sclerosis but does not affect the concentrations of vascular endothelial growth factor or its soluble receptor 1.
    Allanore Y; Borderie D; Lemaréchal H; Ekindjian OG; Kahan A
    Arthritis Res Ther; 2004; 6(4):R309-14. PubMed ID: 15225366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of nitric oxide, advanced oxidation protein products, malondialdehyde, and thiol levels in patients with restless legs syndrome.
    Baskol G; Korkmaz S; Erdem F; Caniklioglu A; Kocyigit M; Aksu M
    Sleep Med; 2012 Apr; 13(4):414-8. PubMed ID: 22469072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress in patients with essential hypertension.
    Tandon R; Sinha MK; Garg H; Khanna R; Khanna HD
    Natl Med J India; 2005; 18(6):297-9. PubMed ID: 16483028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of protein oxidation and lipid peroxidation in patients with rheumatoid arthritis.
    Baskol G; Demir H; Baskol M; Kilic E; Ates F; Karakukcu C; Ustdal M
    Cell Biochem Funct; 2006; 24(4):307-11. PubMed ID: 16142689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls.
    Neri S; Signorelli SS; Torrisi B; Pulvirenti D; Mauceri B; Abate G; Ignaccolo L; Bordonaro F; Cilio D; Calvagno S; Leotta C
    Clin Ther; 2005 Nov; 27(11):1764-73. PubMed ID: 16368447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in the oxidant-antioxidant status in prepubertal children with growth hormone deficiency: effect of growth hormone replacement therapy.
    Mohn A; Marzio D; Giannini C; Capanna R; Marcovecchio M; Chiarelli F
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):537-42. PubMed ID: 16268806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: two clinical trials in healthy volunteers and patients with hereditary angioedema.
    Birjmohun RS; Kees Hovingh G; Stroes ES; Hofstra JJ; Dallinga-Thie GM; Meijers JC; Kastelein JJ; Levi M
    Clin Ther; 2008 Dec; 30(12):2314-23. PubMed ID: 19167590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
    Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
    Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron-induced oxidative stress in haemodialysis patients: a pilot study on the impact of diabetes.
    Van Campenhout A; Van Campenhout C; Lagrou A; Manuel-y-Keenoy B
    Biometals; 2008 Apr; 21(2):159-70. PubMed ID: 17585373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary angioplasty induced oxidative stress and its relation with metoprolol use and plasma homocysteine levels.
    Ciçek D; Tamer L; Pekdemir H; Cin VG; Yildirim H; Kara AA; Yurtdaş M
    Anadolu Kardiyol Derg; 2006 Dec; 6(4):308-13. PubMed ID: 17162274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combined effect of calcium channel blocker Lercanidipine and antioxidants on low-grade systemic inflammation parameters in essential hypertension patients.
    Farah R; Shurtz-Swirski R
    Minerva Cardioangiol; 2008 Oct; 56(5):467-76. PubMed ID: 18813182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased level of advanced oxidation products (AOPP) as a marker of oxidative stress in patients with acute coronary syndrome.
    Skvarilová M; Bulava A; Stejskal D; Adamovská S; Bartek J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun; 149(1):83-7. PubMed ID: 16170393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of ascorbate-rich dialysate to attenuate oxidative stress in maintenance hemodialysis patients.
    Shi XF; Ding F; Zhu QY; Xue J; Lu FM; Gu Y; Lin ST
    Ren Fail; 2005; 27(2):213-9. PubMed ID: 15807188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress markers in hepatitis C infected hemodialysis patients.
    Köken T; Serteser M; Kahraman A; Gökçe C
    J Nephrol; 2002; 15(3):302-7. PubMed ID: 12113603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.